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Ttm role of endogenously synthesized PAF and
prostaglandins on the infection of mouse macrophages
by Letsbmanta (L) amazonensiswas investigated, as well
as the possible correlation between the effects of these
inflammatory mediators with nitric oxide production. It
was found that pretreatment of macrophages with 10- M
of the PAF antagonists, BN-52021 or WEB-2086, increased
macrophage infection by 17 and 59%, respectively. The
cyclooxygenase inhibitor, indomethacin (10 g/ml), in-
duced a significant inhibition which was reversed by
addition of PGE (10-3 M) to the culture medium. These
results suggested that the infection of macrophages by
leisbmanla is inhibited by PAF and enhanced by
prostaglandins and that these mediators are produced by
macrophages during this infection. This was confirmed
by addition of these mediators to the culture medium
before infection; PAF (10-6, 10-9 and 10-1ZM) reduced
significantly the infection whereas PGEz (10- M) induced
a marked enhancement. This effect of exogenous PAF on
macrophage infection was reversed by the two PAF an-
tagonists used in this study as well as by the inhibitor of
nitric oxide synthesis, L-arginine methyl ester (100 mM).
Taken together the data suggest that endogenous produc-
tion of PAF and PGE2 exert opposing effects on
Lesbmana-macrophage interaction and that nitric oxide
may be involved in the augmented destruction of para-
sites induced by PAF.
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Introduction
Species from the Leishmania genus.are protozoans
which present two forms during their life cycle,
promastigotes which live in the digestive tract of the
insect vector and amastigotes, obligate intracellular
parasites which replicate in macrophages of their
vertebrate hosts.
It has been shown that lymphokine activated
mouse macrophages present an increased nitrite
production which correlates with increased
leishmanicidal activity of these cells. 1-3 It seerns that
production of nitric oxide (NO) is more important
than superoxide in the intracellular parasite killing.
Leishmania destruction was shown to be completely
reversed by structural analogues of t-arginine which
inhibit NO production.>3 Conversely, parasite killing
can proceed normally in a macrophage cell line
deficient in the respiratory burst and Kupffer cells
which do not display an oxidative burst in response
to Leishmania. However, Andrade et al. showed that
in the early phase of infection, a very low number of
T cells is present at the site of inoculation of
Leishmania in contrast to a massive influx of
macrophages which rapidly take up the parasites.
Thus, it is unlikely that macrophage activation medi-
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ated by T cells would occur at this stage of infection.
It is more plausible to think that macrophage re-
sponses induced by the parasite would influence the
course of the disease. Indeed, Barcinski et al. pre-
sented evidence that granulocyte-macrophage
colony stimulating factor, a macrophage product,
increases the infectivity of Leishmania amazonensis
by protecting promastigotes from heat-induced
death. A possible role for prostaglandins in the exac-
erbation of the disease in L. major-infected BALB/c
mice was suggested by Farrell and Kirkipatrick. It
has been shown that an increased production of
PGE2, PGF,.=, LTC4, TXB. and PGD2 occurs during the
course of murine infection with L. donovani.9,1
The lipid inflammatory mediators derived from
arachidonic acid metabolism (eicosanoids) and PAF
(platelet activating factor) may exert important
autocrine effects on macrophages. Prostaglandins of
the E series increase cANIP11q3 and by this mechanism
they modulate several macrophage functions. 14 PAF
is an important amplifier of biological processes in
several cell types. In macrophages, PAF inhibits ex-
pression of class II molecules,5 modulates IL-1 pro-
duction in LPS-stimulated monocytes16 and stimulates
TNF production.7 To date, PAF involvement in
Leishmania infection has not been reported.
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The purpose of the present study was to investi-
gate the role of endogenously produced
prostaglandins and PAF in in vitro infection of mouse
macrophages with L. (L.) amazonensis. Macrophages
of BALB/c mice were infected with L. (L.)
amazonensis amastigotes and the phagocytic index
was determined in presence and absence of PAF
antagonists, WEB-2086 or BN-52021, and an inhibitor
of prostaglandin synthesis, indomethacin. The effect
of PAF and PGE added to the culture medium was
also investigated. The possible involvement of NO
was studied by using t-arginine methyl ester (t-
NAME) and an inhibitor of NO synthesis.
Materials and Methods
Animals: BALB/c mice (20-30 g) and outbred Golden
hamsters 2-3 months old from our own animal facil-
ities were used.
Isolation of L. (L.) amazonensis amastigotesfrom ham-
sterfoot pads: L. (L.) amazonensis amastigotes (107
parasites/ml) were transferred every 4 to 6 weeks to
hamsters by inoculation into foot pads. Amastigote
suspensions were prepared by homogenization of
excised lesions in RPMI 1640 medium containing
10% foetal calf serum (FCS) with a Poter glass
homogenizer and the parasites separated by centrifu-
gation at 1 400 xg for 10 min.
Macrophage cultures and L. (L.) amazonensis infection:
Macrophages were collected in phosphate buffered
saline (PBS) from peritoneal cavities of BALB/c mice.
About 4 x 105 cells were allowed to attach to round
13 mm glass coverslips. The non-adherent cells were
removed by rinsing the coverslips with PBS.
Coverslips were placed in 16 mm diameter wells of
Costar plates containing 0.5 ml of RPMI 1640 plus
10% FCS, 100 U of penicillin and 100/g of strepto-
mycin per ml and kept in a 5% CO,. humid atmos-
phere at 37C. After 24 h, L. (L.) amazonensis
amastigotes were added to the macrophage
monolayers at a cell ratio of 3 parasites/macrophage
at 37C. At different times after infection, the
coverslips were washed with PBS, the cells fixed in
absolute methanol for 10 min and stained with
Giemsa, dried, mounted on glass slides and exam-
ined microscopically.
Results were expressed by phagocytic index which
is the product of the percentage of infected
macrophages times the average number of
amastigotes per macrophage.
Evaluation of nitric oxide production: Nitrite is an
oxidation product formed by nitric oxide in an aque-
ous solution. The nitrite concentration was measured
in the culture supernatant media by the method
previously described by Green et al. Briefly, 50/1
aliquots of samples in triplicate were added to 50/1
of Griess reagent in 96-well fiat-bottomed plates. The
absorbance was read at 550 nm (Dynatech MR5000)
after 10 min of reaction and NO concentration was
deduced from a standard curve using concentrations
from 1 to 5/M of sodium nitrite in culture media.
Drug treatments: Indomethacin (10/g/ml) prepared
in Tris-HCl (1M, pH8.0) was added to the
macrophage culture medium 24 h before infection.
The PAF antagonists, WEB-2086 and BN-52021,
were added to the culture medium 1 h before infec-
tion and every 12 h thereafter at concentrations rang-
ing from 10 -5 to 10-TM. The diluent for BN-52021
was provided by the drug company and WEB-2086
was dissolved in PBS. The agonists PAF (10 -6, 10 -9
and 10-12M) and PGE2 (10-5M) were added to the
culture medium at the moment of infection. PAF and
PGE,. were supplied in ethanol and were further
diluted in saline containing 0.25% BSA and PBS,
respectively. The concentration of ethanol in the
culture medium never exceeded 0.1%. The effect of
all diluents used was assayed. At the concentrations
used, the drugs did not significantly affect
macrophage viability as assessed by the Trypan blue
exclusion test.
Drugs and reagents: Cell culture medium (RPMI
1640), indomethacin, t-glutamine, penicillin, strepto-
mycin and N-omega-nitro-t-arginine methyl ester hy-
drochloride (t-NAME) were all purchased from Sigma
Chem. Co. (USA); PGE from UpJohn Co. (USA) and
PAF from Bachem (Switzerland). BN-52021 and
WEB-2086 were kindly supplied by Institut Henri
Beaufour (France) and Boehringer-Ingelheim (Ger-
many), respectively.
Statistical analysis: Student’s t-test for paired samples
and analysis of variance were used to evaluate the
significance of the data (p< 0.01).
Results
Effect ofendogenous PAF andprostaglandins on L. (L.)
amazonensis infected macrophages: In order to inves-
tigate the role of endogenously generated PAF and
prostaglandins in L. (L.)amazonensis macrophage
infection, the macrophages were treated with either
the PAF antagonists (BN-52021 or WEB-2086) or the
cyclooxygenase inhibitor (indomethacin) before in-
fection, and the phagocytic index was determined
48 h later. The two antagonists were added to the
culture medium 1 h before infection and every 12 h
thereafter while indomethacin was added 24h
before infection. The results obtained (Fig. 1) show
that pre-treatment of macrophages with BN-52021 or
WEB-2086 significantly increased the macrophage
infection (17.3 and 59.4% increase, respectively).
Indomethacin, however, induced a significant inhibi-
tion. Addition of PGE2 (10-5M) to indomethacin-
treated macrophages reversed this inhibition.
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FIG. 1. Effect of endogenous PAF and prostaglandins on L. (L.)
amazonensis infected macrophages. Mouse peritoneal macrophages
treated with indomethacin (10 #g/ml), BN-52021 (10-SM), WEB-2086
(10-M) and indomethacin + PGE (10-M) before infection with L. (L.)
amazonensis amastigotes. Indomethacin and the PAF antagonists were
added to the culture medium 24 and h before infection, respectively.
The phagocytic index was determined 48 h later. The controls represent
the values obtained in non-treated macrophages. The results were
obtained by counting at least 200 macrophages per duplicate coverslip.
Error bars show standard deviations of three experiments (*p< 0.01
compared with the non-treated group).
Table 1 shows that WEB-2086 increased the infec-
tion dose dependently, a maximum potentiation be-
ing achieved with 10-SM, although at 10 -6 and
10-7M the drug was also significantly effective. The
control group treated with the diluents of the drugs
did not differ from the non-treated group.
Effect of exogenous PAF and PGE2 on L. (L.)
amazonensis infected macrophages:The results ob-
tained with the PAF antagonists and indomethacin
suggest that PAF and prostaglandins endogenously
generated modulate the in vitro infection. In order to
evaluate whether addition of PAF or PGE,. to the
culture medium influence the infection, these media-
tors were added to the culture medium at the mo-
ment of infection and the phagocytic index deter-
mined 48 h later. The results obtained show that PAF
(10 -6, 10 -9 and 10-12M) reduced the infection dose
dependently whereas PGE,. (10-5M) induced a
marked enhancement (Fig. 2). In some experiments
PAF was added to culture medium 24 h before infec-
tion. In this case it caused 26.5 and 74.6% of inhibi-
Table 1. Effect of WEB-2086 on the infection of macrophages by
L. (L) amazonensis
Concentration
of
WEB-2086
Time after infection (h)
(M) 24 48 72
Control 249.31 + 9.03 408.91 +/- 5.34 658.08 +/- 9.83
10 -7 388.83 +/- 7.27* 505.06 +/- 21.80" 563.71 +/- 11.85"
(55.96) (23.51 (14.34)
10 -6 412.97 +/- 5.80* 577.30 +/- 7.18" 722.26 +/- 8.80*
(57.95) (36.08) (18.62)
10 -s 492.43+ 14.71" 696.72 +/- 16.51" 850.87+/- 17.90"
(88.34) (64.23) (39.76)
Phagocytic index obtained in macrophages infected with L. (L)
amazonensis in the absence (Control) or presence of WEB-2086,
added to the culture medium h before infection. Data represent
the mean +/- S.E.M. of three experiments in duplicate. *p<0.01
compared with the group treated with the diluent. Data in brackets
represent the percentage of enhancement.
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FIG. 2. Effect of exogenous PAF and PGE2 on L. (L.) amazonensis
infected macrophages. Mouse peritoneal macrophages treated with PAF
(10-1, 10-9 and 10-8 M) and PGE2 (10 M) at the moment of infection
with L. (L.) amazonensis amastigotes and phagocytic index determined
48 h later. Non-treated macrophages were used as control. The results
were obtained by counting at least 200 macrophages per duplicate
coverslip. Error bars show standard deviations of six experiments
(*p < 0.01 compared with the non-treated group).
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Table 2. Effect of PAF antagonists on the PAF induced inhibition of
macrophages infection by L. (L) amazonensis amastigotes
Group Treatment AgonisP Phagocytic
(10 -6 M) index
425.57 +/- 10.26
PAF 125.17 +/- 2.36*
III BN-52021 (10-SM) PAF 223.88 +/- 7.76**
IV WEB-2086 (10-s M) PAF 181.95 +/- 4.44**
aThe antagonists were given h before infection.
bPAF was added at the moment of infection.
CThe phagocytic index was determined 48 h after infection of
macrophages with L. (L.) amazonensis.
Data represent the mean + S.E.M. of three experiments in duplicate
*p < 0.01 compared with group I.
**p < 0.01 compared with group I1.
tion at 10 -9 and 10-6M, respectively. At 10-12M it was
no longer effective. The control groups treated with
diluents of PAF and PGE,. did not differ from the non-
treated group.
Effect ofPAF antagonists on PAF induced inhibition of
L. (L.) amazonensis macrophage infection. The ability
of PAF antagonists to inhibit the PAF induced effect
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FIG. 3. Effect of L-NAME on PAF induced inhibition of L. (L.) amazonensis
macrophage infection. Mouse peritoneal macrophages pretreated for
h with L-NAME (100 pM) followed by administration of PAF (10 M) at
the moment of infection with L. (L.) amazonensis amastigotes.
Phagocytic index was determined 48 h later. The results were obtained
by counting at least 200 macrophages per triplicate coverslip. Error bars
show standard deviations of three experiments (*p < 0.01 compared with
the non-treated group).
was investigated. Macrophages were treated with
10 -5 M of the antagonists BN-52021 or WEB-2086, 1 h
before addition of PAF at 10 -6 M concentration to the
culture medium and the phagocytic index was deter-
mined 48 h later. Results presented in Table 2 con-
firmed that PAF induced a marked inhibition of the
phagocytic index and showed that both PAF antago-
nists were able to significantly reverse this effect.
Effect of z-NAME on PAF induced inhibition of L. (L.)
amazonensis macrophage infection: The effect of i:
NAME was studied in combination with PAF. The
macrophages were treated with t-NAME, 1 h before
addition of PAF (10 -6 M) and parasites to the culture
medium and the phagocytic index was determined
48 h later. Controls were carried out by treating the
macrophages with either t-NAME or PAF alone. Fig.
3 shows that the inhibitory effect of PAF on the L. (L.)
amazonensis macrophage infection was reversed by
100 mM t-NAME. This figure also shows that t-NAME
increased the phagocytic index of macrophages treat-
ed with or without PAF. In addition, we assayed the
NO release in the supernatants. The concentration of
nitrites/nitrates in these supernatants was below the
detection limit allowed by the assay employed (data
not shown). The efficacy of t-NAME to inhibit NO
production was tested on macrophages from BCG
infected mice. It was found that BCG-activated
macrophages released 0.929 + 0.054 nmol of NO/105
peritoneal cells after 48h in culture medium
and that pre-treatment of macrophages with 100 mM
of t-NAME significantly inhibited this production
(0.402 + 0.018 nmol/105 peritoneal cells).
Discussion
In leishmaniasis, as in other intracellular parasite
infections, macrophages are both the host and the
effector cell. Several studies focused on the influence
of T cells and their products on macrophages acti-
vation which would lead either to healing or exacer-
bation of the disease (for review see Locksley and
Scott18). However, few studies have analysed the
consequences of the initial interaction between
macrophage and parasites on parasite multiplication.
In the present work we showed that treatment of
macrophages with indomethacin, an inhibitor of
prostaglandins synthesis, before infection with L. (L.)
amazonensis significantly inhibited parasite growth.
This result indicates that prostaglandins are released
by macrophages during the infection and that they
favour parasite survival possibly by inhibiting acti-
vation of the macrophage. Since the effect of
indomethacin was reversed by the addition of PGE2
to the culture medium, it is likely that this
cyclooxygenase metabolite is the one responsible for
the observed effect. Our findings are in agreement
with those reported by Buchmtller-Rouiller et al. 19
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showing that PGE inhibits the leishmanicidal activity
of macrophages activated with ionophore and LPS.
That macrophages are able to produce
prostaglandins when infected with Leishmania has
been shown by studies in vitro and in vivo.9’1
Prostaglandin E is known to exert negative feedback
on macrophage activation,2 an effect probably medi-
ated by an increased intracellular level of cal[P. 19 In
our model, it is probable that prostaglandins gener-
ated by the infected macrophages inhibited their
capacity to control parasite multiplication. In support
of this assumption it has been shown that treatment
of susceptible BALB/c mice infected with L. major
with indomethacin significantly inhibited the number
of metastatic lesions. However, this effect might not
rely entirely on inhibition of macrophage function
since prostaglandins also inhibit lymphocyte prolif-
eration induced by Con A and parasite antigens.
To study the role of PAF on this infection, two
specific PAF antagonist, BN-5202121 or XVEB-208622
were added to the culture medium before infection
with L. (L.) amazonensis. These treatments increased
the phagocytic index indicating that PAF is generated
endogenously by infected macrophages and in turn
it exerts a marked inhibition of parasite growth. This
was confirmed by experiments where PAF was
added exogenously to culture medium of infected
macrophages. In this case, a clear dose dependent
inhibition of parasite multiplication was observed.
We also showed that the doses of the PAF antag-
onists used in this study were effective to antagonize
PAF receptors in murine macrophages since both
antagonists were able to reverse the inhibitory effect
of PAF.
It is known that macrophages can generate PAF
when properly stimulated;17 however, to our know-
ledge this is the first report to show that PAF exerts
such a relevant effect on leishmanial infection.
Another substance that is recognized as a potent
leishmanicidal agent in vivo and in vitro is nitric
oxide (for review see Liew and C0x23). Thus, we
reasoned whether the inhibitory effect of PAF on
leishmanial growth could be mediated by NO. To this
end we added an inhibitor of NO synthesis (t-NAME)
to infected macrophages in the presence or absence
of PAF. In both situations t-NAME increased parasite
multiplication. These results, although indirect,
strongly suggest the participation of NO as the active
molecule that mediates the PAF induced macrophage
leishmanicidal activity.
The present work showed that PGE has a
stimulatory effect whereas PAF has an inhibitory
effect on L. (L.) amazonensis infection in mouse
macrophages. It also showed that the leishmanicidal
effect of PAF is mediated by NO. It will be of interest
to measure the levels of PGE, and PAF released by
infected macrophages obtained from resistant and
susceptible strains of mouse and also to determine
the effect of these lipid mediators on the course of
in vivo infection.
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